Blackrock Neurotech - Bryant McGill

# Blackrock Neurotech **Entity class:** Concept or analytic term **Domain:** Implantable Brain-Computer Interfaces / Neural Recording / Clinical Translation **Doc Type:** Institution and Reference-Architecture Node **Maturity:** Developed ## Definition **Blackrock Neurotech is an implantable brain-computer-interface company whose Utah Array and NeuroPort lineage has supported long-running human neural-interface research.** In this research cluster, Blackrock is the mature invasive performance, experimental-hardware, and regulatory reference architecture against which less-invasive systems can be compared. ## Subsense bridges [[wiki/Subsense BCI|Subsense BCI]] has at least two direct personnel-and-practice bridges to Blackrock: - Subsense identifies **Lindsey Jardine** as its Regulatory Advisor, describes her as a former Vice President of Clinical and Regulatory at Blackrock Neurotech, and says she is leading Subsense's FDA TAP Pilot and Breakthrough-neurotechnology strategies. - Subsense identifies **Sergey Stavisky** as a Scientific Advisor. Stavisky's neural-interface research has used Blackrock NeuroPort arrays, and his intellectual-property record includes BCI technology licensed to Blackrock. These are distinct pathways: clinical-regulatory translation on one side and scientific, hardware, and IP experience on the other. They show a shared developmental ecology and relevant expertise moving across institutional boundaries. They do not establish that Blackrock owns, controls, validates, or has transferred a complete technology to Subsense. ## Tether ownership In April 2024, [[wiki/Tether Evo|Tether Evo]] invested $200 million in Blackrock Neurotech, making Tether the majority stakeholder. This creates a documented capital route from a crypto-native institution into an established BCI company. The ownership relationship is not evidence that Tether invested in Subsense. ## Comparative role Blackrock's implanted-electrode systems and human-research history provide a high-resolution invasive benchmark. Subsense's proposed discontinuity is the relocation of part of the interface into administered functional nanoparticles, while [[wiki/Merge Labs|Merge Labs]] is developing a separate biology-device-AI and ultrasound route. Comparison does not imply corporate succession or common technical origin. ## Routes [[wiki/Subsense BCI|Subsense BCI]] · [[wiki/Tether Evo|Tether Evo]] · [[wiki/Merge Labs|Merge Labs]] · [[wiki/Neural Interfaces and Continuity Architecture|Neural Interfaces and Continuity Architecture]] · [[wiki/Neural Data Sovereignty|Neural Data Sovereignty]] ## Sources / Provenance - Blackrock Neurotech, [Tether invested $200M in Blackrock Neurotech](https://blackrockneurotech.com/insights/tether-invested-200m-in-blackrock-neurotech-accelerating-development-and-commercialization-of-implantable-bci-technology/), April 29, 2024. - Subsense, [Team, collaborators, and advisors](https://subsense-bci.com/about-us/). - Bryant-supplied Blackrock–Subsense research memorandum, September 7, 2026 — source of the multi-path topology and research questions. ## Neurotech source route **Collection:** [[collections/Neurotech|Neurotech]] **Source article:** [[articles/The Organic-Synthetic Brain Atlas|The Organic-Synthetic Brain Atlas]] ## Relationships [[wiki/Blackrock Neurotech|Blackrock Neurotech]] is related to [[wiki/Utah Array|Utah Array]] as clinical and research intracortical interface systems.  This entry is routed through [[collections/Neurotech|Neurotech]] and [[collections/Consciousness Continuity|Consciousness Continuity]]. Its source context is developed in [[articles/Technologies for Consciousness Mapping and Transfer|Technologies for Consciousness Mapping and Transfer]], [[articles/The Architecture of Continuity and Emerging Neuroinformatics Standards|The Architecture of Continuity and Emerging Neuroinformatics Standards]], [[articles/The Organic-Synthetic Brain Atlas|The Organic-Synthetic Brain Atlas]], and [[articles/2026 Annual Report on Brain-Computer Interfaces|2026 Annual Report on Brain-Computer Interfaces]]. Status-qualified source edges are preserved in the terminal Research Edges section. ### People and institutional relationships - **Blackrock Neurotech** was co-founded by [[wiki/Florian Solzbacher|Florian Solzbacher]]. 2008. - **Blackrock Neurotech** was co-founded by [[wiki/Marcus Gerhardt|Marcus Gerhardt]]. 2008. - **Blackrock Neurotech** is associated with Subsense. Lindsey Jardine formerly led clinical/regulatory work at Blackrock and now advises Subsense. ### Key Relationships - **Blackrock Neurotech** is associated with [[wiki/Utah Array|Utah Array]]. - **Blackrock Neurotech** is associated with [[wiki/Cortec|CorTec]]. Implantable neurodevice portfolio partnership; retain source validation if expanded. - The source corpus interprets the relationship this way: **Blackrock Neurotech** is associated with Subsense. Penetrating silicon electrodes versus distributed functional nanoparticles + external wearable transceiver; useful comparison axis, not a business relationship. ### Technology and research relationships - **Blackrock Neurotech** develops [[wiki/MoveAgain BCI|MoveAgain BCI]]. Utah Array-centered clinical product; FDA Breakthrough designation history. ### Funding, business, and licensing - [[wiki/Tether Evo|Tether Evo]] is associated with **Blackrock Neurotech**. $200M investment announced 2024-04-29. ### Additional Documented Relationships - **Blackrock Neurotech** is associated with [[wiki/Subsense BCI|Subsense BCI]]. Lindsey Jardine formerly led clinical/regulatory work at Blackrock and now advises Subsense.  ## Neurotech cluster route **Collection:** [[collections/Neurotech|Neurotech]] **Source articles:** [[articles/2026 Annual Report on Brain-Computer Interfaces|2026 Annual Report on Brain-Computer Interfaces]] · [[articles/The Organic-Synthetic Brain Atlas|The Organic-Synthetic Brain Atlas]] ## Related Work in the Corpus  - In [[articles/The Organic-Synthetic Brain Atlas|The Organic-Synthetic Brain Atlas]], **Movement VII — Interface Deployment: The Neurointerface Stack from Wearable to Implanted** provides the narrative context for **Blackrock Neurotech**: Wiki route: brain-computer interfaces · non-invasive BCI · invasive BCI · Neuralink · Synchron · Precision Neuroscience · Blackrock Neurotech · Paradromics · BCI HID. - In [[articles/The Organic-Synthetic Brain Atlas|The Organic-Synthetic Brain Atlas]], **VII.8 — BlackRock Neurotech, Paradromics, and the Continuing Ecosystem** provides the narrative context for **Blackrock Neurotech**: BlackRock Neurotech is the longest-operating commercial implanted-BCI company, with the Utah Array — a 96- or 100-electrode penetrating silicon array originally developed by Richard Normann at the University of Utah in the 1990s…  ## Research Edges  #### Master relationship graph patch — 2026-09-10 **Collection:** [[collections/Neurotech|Neurotech]] **Relationship source:** [[research/Neurotechnology Ecosystem Relationship Graph - 2026-09-10|Neurotechnology Ecosystem Relationship Graph — 2026-09-10]] **Related source articles:** [[articles/The Architecture of Continuity and Emerging Neuroinformatics Standards|The Architecture of Continuity and Emerging Neuroinformatics Standards]] · [[articles/2026 Annual Report on Brain-Computer Interfaces|2026 Annual Report on Brain-Computer Interfaces]] · [[articles/The Organic-Synthetic Brain Atlas|The Organic-Synthetic Brain Atlas]] #### Outgoing typed edges - **Edge 267 — `co_founded_by` → [[wiki/Florian Solzbacher|Florian Solzbacher]]** — **VERIFIED**; evidence `BLACKROCK_STORY`. 2008. - **Edge 268 — `co_founded_by` → [[wiki/Marcus Gerhardt|Marcus Gerhardt]]** — **VERIFIED**; evidence `BLACKROCK_STORY`. 2008. - **Edge 271 — `manufactures` → [[wiki/Utah Array|Utah Array]]** — **VERIFIED**; evidence `BLACKROCK_UTAH`. Commercial research platform. - **Edge 274 — `develops` → [[wiki/MoveAgain BCI|MoveAgain BCI]]** — **VERIFIED**; evidence `BLACKROCK_TECH`. Utah Array-centered clinical product; FDA Breakthrough designation history. - **Edge 278 — `personnel_line_to` → [[wiki/Subsense BCI|Subsense]]** — **VERIFIED**; evidence `SUB_ABOUT`. Lindsey Jardine formerly led clinical/regulatory work at Blackrock and now advises Subsense. - **Edge 279 — `partners_with` → [[wiki/Cortec|CorTec]]** — **VERIFIED_SECONDARY**; evidence `CORPUS_ATLAS`. Implantable neurodevice portfolio partnership; retain source validation if expanded. - **Edge 280 — `technological_contrast` → [[wiki/Subsense BCI|Subsense]]** — **ANALYTIC**; evidence `BLACKROCK_UTAH`, `SUB_TECH`. Penetrating silicon electrodes versus distributed functional nanoparticles + external wearable transceiver; useful comparison axis, not a business relationship. #### Incoming typed edges - **Edge 275 — [[wiki/Tether Evo|Tether Evo]] `invested_in` → this entry** — **VERIFIED**; evidence `BLACKROCK_TETHER`. $200M investment announced 2024-04-29.   #### Consciousness mapping and transfer graph patch — 2026-09-10 **Collections:** [[collections/Neurotech|Neurotech]] · [[collections/Consciousness Continuity|Consciousness Continuity]] **Relationship source:** [[research/Consciousness Mapping and Transfer Ecosystem Relationship Graph - 2026-09-10|Consciousness Mapping and Transfer Ecosystem Relationship Graph — 2026-09-10]] **Related source articles:** [[articles/Technologies for Consciousness Mapping and Transfer|Technologies for Consciousness Mapping and Transfer]] · [[articles/The Architecture of Continuity and Emerging Neuroinformatics Standards|The Architecture of Continuity and Emerging Neuroinformatics Standards]] · [[articles/2026 Annual Report on Brain-Computer Interfaces|2026 Annual Report on Brain-Computer Interfaces]] · [[articles/The Organic-Synthetic Brain Atlas|The Organic-Synthetic Brain Atlas]] #### Outgoing typed edges - **Edge 267 — `co_founded_by` → [[wiki/Florian Solzbacher|Florian Solzbacher]]** — **PRIOR_NEUROTECH_VERIFIED**; evidence `BLACKROCK_STORY`. 2008. - **Edge 268 — `co_founded_by` → [[wiki/Marcus Gerhardt|Marcus Gerhardt]]** — **PRIOR_NEUROTECH_VERIFIED**; evidence `BLACKROCK_STORY`. 2008. - **Edge 271 — `manufactures` → [[wiki/Utah Array|Utah Array]]** — **PRIOR_NEUROTECH_VERIFIED**; evidence `BLACKROCK_UTAH`. Commercial research platform. - **Edge 274 — `develops` → [[wiki/MoveAgain BCI|MoveAgain BCI]]** — **PRIOR_NEUROTECH_VERIFIED**; evidence `BLACKROCK_TECH`. Utah Array-centered clinical product; FDA Breakthrough designation history. - **Edge 278 — `personnel_line_to` → [[wiki/Subsense BCI|Subsense]]** — **PRIOR_NEUROTECH_VERIFIED**; evidence `SUB_ABOUT`. Lindsey Jardine formerly led clinical/regulatory work at Blackrock and now advises Subsense. - **Edge 279 — `partners_with` → [[wiki/Cortec|CorTec]]** — **PRIOR_NEUROTECH_VERIFIED_SECONDARY**; evidence `CORPUS_ATLAS`. Implantable neurodevice portfolio partnership; retain source validation if expanded. - **Edge 280 — `technological_contrast` → [[wiki/Subsense BCI|Subsense]]** — **PRIOR_NEUROTECH_ANALYTIC**; evidence `BLACKROCK_UTAH`, `SUB_TECH`. Penetrating silicon electrodes versus distributed functional nanoparticles + external wearable transceiver; useful comparison axis, not a business relationship. #### Incoming typed edges - **Edge 275 — [[wiki/Tether Evo|Tether Evo]] `invested_in` → this entry** — **PRIOR_NEUROTECH_VERIFIED**; evidence `BLACKROCK_TETHER`. $200M investment announced 2024-04-29.  ## Research Inferences  These entries translate the forward-looking register in [[research/Research Inferences|Research Inferences]] into ordinary wiki prose. The tier labels apply to the inference, not automatically to every factual anchor inside it. The interpretive frame comes from [[articles/Technologies for Consciousness Mapping and Transfer|Technologies for Consciousness Mapping and Transfer]] and [[articles/Mind Uploading and AI — The Host is Reusable and the Person is the Delta|Mind Uploading and AI — The Host is Reusable and the Person is the Delta]]. Collection route: [[collections/Neurotech|Neurotech]]. - **INF-0003 — Established.** The Utah Array's multi-decade chronic dwell in human cortex, including a single participant past nine years, is the only long-duration dataset the field owns. Every claim about lifetime continuity hardware is currently underwritten by that one electrode geometry, which makes array longevity the most load-carrying unresolved variable in the stack.